Refine
Year of publication
- 2015 (75) (remove)
Document Type
- Article (45)
- Doctoral Thesis (19)
- Conference Proceeding (4)
- Review (4)
- Postprint (2)
- Preprint (1)
Is part of the Bibliography
- yes (75)
Keywords
- Endothelin (3)
- Inflammation (2)
- Solanaceae (2)
- Sphingosine kinase (2)
- cells (2)
- coenzyme-a (2)
- database (2)
- energy-metabolism (2)
- glutathione (2)
- hallervorden-spatz-syndrome (2)
- inflammation (2)
- mobility-mass spectrometry (2)
- model (2)
- neurodegeneration (2)
- neurotoxicity (2)
- type 2 diabetes (2)
- 1-Phenylethanol (1)
- 2-Phenylethanol (1)
- 3,5-Dimethoxytoluene (1)
- ADPKD (1)
- AOAC (1)
- APOM protein (1)
- Abrus precatorius (1)
- Acid sphingomyelinase (1)
- Adipositas (1)
- Akt signaling (1)
- Alcohol dependence (1)
- Alkohol (1)
- Alpine metamorphism (1)
- Antibiotikaresistenz (1)
- Anxiety (1)
- Apoptosis (1)
- Arsenolipids (1)
- Aryl-hydrocarbon receptor (1)
- BMP4 (1)
- BPA (1)
- Beta-amylase (1)
- Bioaktivität (1)
- Bioavailability (1)
- Biomarker (1)
- Bisphenol A (1)
- Blood platelets (1)
- Brassicaceae (1)
- Caco-2 intestinal barrier model (1)
- Caenorhabditis elegans (1)
- Camellia sinensis (1)
- Cameroon (1)
- Cardiovascular (1)
- Carotenoid (1)
- Case-control study (1)
- Catechins (1)
- Ceramide (1)
- Chronic kidney disease (1)
- Clinical (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colon cancer (1)
- Connective tissue growth factor (1)
- Cyp2b1 (1)
- Cytotoxicity (1)
- DNA methylation (1)
- Darmbakterium (1)
- Dengue (1)
- Depression (1)
- Development (1)
- Diabetic cardiomyopathy (1)
- Diabetic nephropathy (1)
- Diagnostic (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Disease (1)
- Doehlert design (1)
- Dopamine (1)
- Drug metabolism (1)
- ET-1 (1)
- ETA (1)
- ETB (1)
- Endocrine disruption (1)
- Endothelial cells (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Epigenetic (1)
- Equol (1)
- Extraction (1)
- Fabaceae (1)
- Fibrosis (1)
- Firefly luciferase inhibition (1)
- Floral scent compound (1)
- Food Chain (1)
- Freeze-fracturing (1)
- Gastrointestinal tract (1)
- Gene expression (1)
- Geschmacksrezeptor (1)
- Glucagon (1)
- Glycerophospholipids (1)
- HEK293 (1)
- HPLC (1)
- Hepatotoxicity (1)
- High pressure - low temperature treatments (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Hypoxia (1)
- IGF-1 (1)
- Insulin-induzierte Hypoglykämie (1)
- Isoflavone (1)
- Isotope-dilution analysis (1)
- Kinetik (1)
- Körpergewichsterhalt (1)
- Körpergewichtsverlust (1)
- Lebensmittelkette (1)
- Life science (1)
- Lipid (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Lu-Hf geochronology (1)
- Lysophosphatidylcholines (1)
- MRSA (1)
- Manganese (1)
- Mass spectrometry (1)
- Membrane (1)
- Menderes Massif (1)
- Mercuric mercury (1)
- Mesoangioblasts (1)
- Methylmercury (1)
- Mice (1)
- Micellar caseins (1)
- Microbial degradation (1)
- Migration (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Morphogenesis (1)
- Motor coordination (1)
- Multiple herbivory (1)
- Myoblasts (1)
- Myzus persicae (1)
- Neurotoxicity (1)
- Nitric oxide (1)
- Nuclear receptor (1)
- Oxidative stress (1)
- PBPK (1)
- PBTK (1)
- Pea flour (1)
- Pea protein isolate (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Phenylpropanoids (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Physicochemical properties (1)
- Plasma (1)
- Plasmalogens (1)
- Polymorphismus (1)
- Prediabetes (1)
- Presystemic metabolism (1)
- Procyanidins (1)
- Proteine (1)
- Pulmonary arterial hypertension (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- Reduktase (1)
- Relaxin (1)
- Resistance (1)
- Rezeptorscreening (1)
- Rosa x level (1)
- S1P(3) receptor (1)
- SU5416 (1)
- Serotonin (1)
- Short chain dehydrogenase (1)
- Solanum lycopersicum (1)
- Spectrophotometry (1)
- Sphingolipids (1)
- Sphingomyelin (1)
- Sphingosine 1phosphate (1)
- Structural changes (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- TTC (1)
- Tandem mass spectrometry (1)
- Tas1r1 (1)
- Technofunctional properties (1)
- Tetranychus urticae (1)
- Thiomersal (1)
- Three phase partitioning (1)
- Thyroid hormone (1)
- ToF-SIMS imaging (1)
- Toxicity (1)
- Toxikokinetik (1)
- Transactivation assay (1)
- Transcriptomics (1)
- Transforming growth factor beta (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- UDP-glucuronosyltransferase (1)
- Volatile compound (1)
- Whey proteins (1)
- Xenobesity (1)
- Yolk (1)
- acid sphingomyelinase (1)
- acute kidney injury (1)
- albuminuria (1)
- alcohol (1)
- aphids (1)
- atherosclerosis (1)
- auditory neurons (1)
- bioactivity (1)
- body weight loss (1)
- body weight maintenance (1)
- carotenoids (1)
- carotenoids bioavailability (1)
- ceramide (1)
- chronic kidney disease (1)
- crop (1)
- differentiation (1)
- equol (1)
- first trimester (1)
- garnet (1)
- genomics (1)
- gestational diabetes mellitus (GDM) (1)
- glucagon (1)
- glycaemic control (1)
- gut microbiota (1)
- high-density lipoprotein (HDL) (1)
- hypertension (1)
- iCheck (1)
- in silico (1)
- insulin (1)
- insulin-induced hypoglycemia (1)
- integrins (1)
- isoflavones (1)
- kidney dysfunction (1)
- kinetics (1)
- large for gestational age fetus (LGA) (1)
- linagliptin (1)
- metabolomics (1)
- microbiomics (1)
- micronutrient deficiencies (1)
- obesity (1)
- plant volatiles (1)
- platelets (1)
- polycystic kidney disease (1)
- polymorphism (1)
- proliferation (1)
- protein (1)
- protein microheterogeneity (1)
- proteomics (1)
- reductase (1)
- retinol (ROH) (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- sphingolipids (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- survival (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- systemic response (1)
- taste receptor (1)
- taste receptor screening (1)
- terpenoids (1)
- toxicology (1)
- transcriptomics (1)
- transthyretin (TTR) (1)
- tumor-metastasis (1)
- type 2 diabetes mellitus (1)
- umami (1)
- vitamin A deficiency (1)
- zinc/iron supplementation (1)
- Übertragung (1)
Institute
- Institut für Ernährungswissenschaft (75) (remove)
Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.
Die Phyllosphäre
(2015)
Aminosäuren sind lebensnotwendige Moleküle für alle Organismen. Ihre Erkennung im Körper ermöglicht eine bedarfsgerechte Regulation ihrer Aufnahme und ihrer Verwertung. Welcher Chemosensor für diese Erkennung jedoch hauptverantwortlich ist, ist bisher unklar. In der vorliegenden Arbeit wurde die Rolle der Umamigeschmacksrezeptoruntereinheit Tas1r1 jenseits ihrer gustatorischen Bedeutung für die Aminosäuredetektion in der Mundhöhle untersucht.
In der histologischen Tas1r1-Expressionsanalyse nichtgustatorischer Gewebe der Mauslinie Tas1r1-Cre/ROSA26-tdRFP wurde über die Detektion des Reporterproteins tdRFP die Expression des Tas1r1 in allen untersuchten Geweben (Speiseröhre, Magen, Darm, Bauchspeicheldrüse, Leber, Niere, Muskel- und Fettgewebe, Milz, Thymus, Lymphknoten, Lunge sowie Hoden) nachgewiesen. Mit Ausnahme von Dünndarm und Hoden gelang hierbei der Nachweis erstmals spezifisch auf zellulärer Ebene. Caecum und Lymphknoten wurden zudem neu als Expressionsorte des Tas1r1 identifiziert.
Trotz der beobachteten weiten Verbreitung des Tas1r1 im Organismus – unter anderem auch in Geweben, die für den Proteinstoffwechsel besonders relevant sind – waren im Zuge der durchgeführten Untersuchung potentieller extraoraler Funktionen des Rezeptors durch phänotypische Charakterisierung der Mauslinie Tas1r1-BLiR nur schwache Auswirkungen auf Aminosäurestoffwechsel bzw. Stickstoffhaushalt im Falle eines Tas1r1-Knockouts detektierbar. Während sich Ernährungsverhalten, Gesamtphysiologie, Gewebemorphologie sowie Futterverdaulichkeit unverändert zeigten, war die renale Stickstoffausscheidung bei Tas1r1-Knockout-Mäusen auf eiweißarmer sowie auf eiweißreicher Diät signifikant verringert. Eine Überdeckung der Auswirkungen des Tas1r1-Knockouts aufgrund kompensatorischer Effekte durch den Aminosäuresensor CaSR oder den Peptidsensor Gpr93 war nicht nachweisbar. Es bleibt offen, ob andere Mechanismen oder andere Chemosensoren an einer Kompensation beteiligt sind oder aber Tas1r1 in extraoralem Gewebe andere Funktionen als die der Aminosäuredetektion übernimmt. Unterschiede im extraoralen Expressionsmuster der beiden Umamirezeptor-untereinheiten Tas1r1 und Tasr3 lassen Spekulationen über andere Partner, Liganden und Funktionen zu.
Zellbasierte heterologe Expressionssysteme bieten ein einfaches und schnelles Verfahren, um neue Süßstoffe oder Süßverstärker zu finden. Unter Verwendung eines solchen Testsystems, konnte ich in Zusammenarbeit mit der Symrise AG, Holzminden und dem Institut für Pflanzenbiochemie in Halle/Saale die vietnamesische Pflanze Mycetia balansae als Quelle eines neuen Süßstoffs identifizieren. Deren Hauptkomponenten, genannt Balansine, aktivieren spezifisch den humanen Süßrezeptor. Chimäre Rezeptoren zeigten, dass die amino-terminalen Domänen der Süßrezeptoruntereinheiten, welche ein Großteil der Liganden des Süßrezeptors binden, für dessen Aktivierung durch Balansin A nicht notwendig sind.
Voraussetzung für die Anwendung zellbasierter Testsysteme zum Auffinden neuer Süßstoffe ist jedoch, dass süße Substanzen gesichert identifiziert werden, während nicht süße Substanzen zuverlässig keine Rezeptoraktivierung aufweisen. Während in HEK293 TAS1R2 TAS1R3To Galpha15i3-Zellen Süßrezeptoraktivierung gegenüber nicht süß schmeckenden Substanzen beobachtet wurde, konnte mit den HEK293PEAKrapid Galpha15-Zellen ein zuverlässiges Testsystem identifiziert, welches den Süßgeschmack der untersuchten Substanzen widerspiegelte.
Es fanden sich keine Hinweise, dass akzessorische Proteine oder verwandte Rezeptoren des Süßrezeptors das unterschiedliche Verhalten der Zellen verursachen. Es konnte gezeigt werden, dass die Verwendung unterschiedlicher G-Proteine die Signalamplituden des Süßrezeptors beeinflusst, die Unterschiede zwischen den Zellsystemen jedoch nicht vollständig erklärt. Keine der untersuchten Galpha-Proteinchimären spiegelte die intrinsische Süße der Substanzen wider.
Wenn auch nicht ursächlich für die Diskrepanz zwischen Süßrezeptoraktivierung in vitro und Süßgeschmack in vivo, so weisen die Ergebnisse dieser Arbeit auf eine Interaktion der Süßrezeptoruntereinheiten mit dem humanen Calcium-sensing Rezeptor hin. Vanillin und Ethylvanillin konnten als neue Agonisten des Calcium-sensing Rezeptors identifiziert werden.
Wie die vorliegende Arbeit zeigt, können sich kleine Unterschiede im Zellhintergrund deutlich auf die Funktionsweise heterolog exprimierter Rezeptoren auswirken. Dies zeigt wie wichtig die Wahl der Zellen für solche Screeningsysteme ist.
Obesity is a major health problem for many developing and industrial countries. Increasing rates reach almost 50 % of the population in some countries and related metabolic diseases including cardiovascular events and T2DM are challenging the health systems. Adiposity, an increase in body fat mass, is a major hallmark of obesity. Adipose tissue is long known not only to store lipids but also to influence whole-body metabolism including food intake, energy expenditure and insulin sensitivity. Adipocytes can store lipids and thereby protect other tissue from lipotoxic damage. However, if the energy intake is higher than the energy expenditure over a sustained time period, adipose tissue will expand. This can lead to an impaired adipose tissue function resulting in higher levels of plasma lipids, which can affect other tissue like skeletal muscle, finally leading to metabolic complications. Several studies showed beneficial metabolic effects of weight reduction in obese subjects immediately after weight loss. However, weight regain is frequently observed along with potential negative effects on cardiovascular risk factors and a high intra-individual response.
We performed a body weight maintenance study investigating the mechanisms of weight maintenance after intended WR. Therefore we used a low caloric diet followed by a 12-month life-style intervention. Comprehensive phenotyping including fat and muscle biopsies was conducted to investigate hormonal as well as metabolic influences on body weight regulation. In this study, we showed that weight reduction has numerous potentially beneficial effects on metabolic parameters. After 3-month WR subjects showed significant weight and fat mass reduction, lower TG levels as well as higher insulin sensitivity. Using RNA-Seq to analyse whole fat and muscle transcriptome a strong impact of weight reduction on adipose tissue gene expression was observed. Gene expression alterations over weight reduction included several cellular metabolic genes involved in lipid and glucose metabolism as well as insulin signalling and regulatory pathways. These changes were also associated with anthropometric parameters assigning body composition. Our data indicated that weight reduction leads to a decreased expression of several lipid catabolic as well as anabolic genes. Long-term body weight maintenance might be influenced by several parameters including hormones, metabolic intermediates as well as the transcriptional landscape of metabolic active tissues. Our data showed that genes involved in biosynthesis of unsaturated fatty acids might influence the BMI 18-month after a weight reduction phase. This was further supported by analysing metabolic parameters including RQ and FFA levels. We could show that subjects maintaining their lost body weight had a higher RQ and lower FFA levels, indicating increased metabolic flexibility in subjects.
Using this transcriptomic approach we hypothesize that low expression levels of lipid synthetic genes in adipose tissue together with a higher mitochondrial activity in skeletal muscle tissue might be beneficial in terms of body weight maintenance.
Inflammation in Cachexia
(2015)
Epigenetic silencing of tumor suppressor genes is involved in early transforming events and has a high impact on colorectal carcinogenesis. Likewise, colon cancers that derive from chronically inflamed bowel diseases frequently exhibit epigenetic changes. But there is little data about epigenetic aberrations causing colorectal cancer in chronically inflamed tissue. The aim of the present study was to evaluate the aberrant gain of methylation in the gene promoters of VIM, TFPI2 and ITGA4 as putative early markers in the development from inflamed tissue via precancerous lesions toward colorectal cancer.
Initial screening of different cancer cell lines by using methylation-specific PCR revealed a putative colon cancer-specific methylation pattern. Additionally, a demethylation assay was performed to investigate the methylation-dependent gene silencing of ITGA4. The candidate markers were analyzed in colonic tissue specimens from patients with colorectal cancer (n = 15), adenomas (n = 76), serrated lesions (n = 13), chronic inflammation (n = 10) and normal mucosal samples (n = 9).
A high methylation frequency of VIM (55.6 %) was observed in normal colon tissue, whereas ITGA4 and TFPI2 were completely unmethylated in controls. A significant gain of methylation frequency with progression of disease as well as an age-dependent effect was detectable for TFPI2. ITGA4 methylation frequency was high in precancerous and cancerous tissues as well as in inflammatory bowel diseases (IBD).
The already established methylation marker VIM does not permit a specific and sensitive discrimination of healthy and neoplastic tissue. The methylation markers ITGA4 and TFPI2 seem to be suitable risk markers for inflammation-associated colon cancer.